What is the official website of Gateway Analytical, an Aptar Pharma company ?

The official website of Gateway Analytical, an Aptar Pharma company is http://www.gatewayanalytical.com.

What is Gateway Analytical, an Aptar Pharma company's cybersecurity risk score?

Gateway Analytical, an Aptar Pharma company has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Gateway Analytical, an Aptar Pharma company experienced?

According to Rankiteo, Gateway Analytical, an Aptar Pharma company currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Gateway Analytical, an Aptar Pharma company been affected by any supply chain cyber incidents ?

According to Rankiteo, Gateway Analytical, an Aptar Pharma company has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Gateway Analytical, an Aptar Pharma company have SOC 2 Type 1 certification ?

According to Rankiteo, Gateway Analytical, an Aptar Pharma company is not certified under SOC 2 Type 1.

Does Gateway Analytical, an Aptar Pharma company have SOC 2 Type 2 certification ?

According to Rankiteo, Gateway Analytical, an Aptar Pharma company does not hold a SOC 2 Type 2 certification.

Does Gateway Analytical, an Aptar Pharma company comply with GDPR ?

According to Rankiteo, Gateway Analytical, an Aptar Pharma company is not listed as GDPR compliant.

Does Gateway Analytical, an Aptar Pharma company have PCI DSS certification ?

According to Rankiteo, Gateway Analytical, an Aptar Pharma company does not currently maintain PCI DSS compliance.

Does Gateway Analytical, an Aptar Pharma company comply with HIPAA ?

According to Rankiteo, Gateway Analytical, an Aptar Pharma company is not compliant with HIPAA regulations.

Does Gateway Analytical, an Aptar Pharma company have ISO 27001 certification ?

According to Rankiteo,Gateway Analytical, an Aptar Pharma company is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Gateway Analytical, an Aptar Pharma company operate in ?

Gateway Analytical, an Aptar Pharma company operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Gateway Analytical, an Aptar Pharma company have ?

Gateway Analytical, an Aptar Pharma company employs approximately 40 people worldwide.

Does Gateway Analytical, an Aptar Pharma company own any subsidiaries ?

Gateway Analytical, an Aptar Pharma company presently has no subsidiaries across any sectors.

How many LinkedIn followers does Gateway Analytical, an Aptar Pharma company have ?

Gateway Analytical, an Aptar Pharma company's official LinkedIn profile has approximately 1,013 followers.

What is the NAICS classification code for Gateway Analytical, an Aptar Pharma company ?

Gateway Analytical, an Aptar Pharma company is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Gateway Analytical, an Aptar Pharma company have a Crunchbase profile ?

No, Gateway Analytical, an Aptar Pharma company does not have a profile on Crunchbase.

Does Gateway Analytical, an Aptar Pharma company have a LinkedIn profile ?

Yes, Gateway Analytical, an Aptar Pharma company maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/gateway-analytical.

How many cybersecurity incidents has Gateway Analytical, an Aptar Pharma company experienced ?

As of August 28, 2026, Rankiteo reports that Gateway Analytical, an Aptar Pharma company has not experienced any cybersecurity incidents.

How many peer or competitor companies does Gateway Analytical, an Aptar Pharma company have ?

Gateway Analytical, an Aptar Pharma company has an estimated 5,746 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

GAAPC

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

Gateway Analytical, an Aptar Pharma company Vendor Cyber Rating & Cyber Score

gatewayanalytical.com

Add Your Compliance Badge

Gateway Analytical is the innovative analytical testing laboratory that businesses around the world trust to provide solutions for their most challenging foreign particulate analysis, foreign particulate identification and materials analysis needs. Gateway’s expert scientists, specialized testing techniques and comprehensive analysis methods allow the company to deliver the fast, accurate and reliable results that customers in the pharmaceutical, materials and medical device industries demand. To learn more about Gateway Analytical and how it is making the world healthier and safer, visit www.gatewayanalytical.com.

GAAPC A.I CyberSecurity Scoring

Scoring History

GAAPC

Gateway Analytical, an Aptar Pharma company CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

GAAPC Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for GAAPC

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Gateway Analytical, an Aptar Pharma company in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Gateway Analytical, an Aptar Pharma company in 2026.

Incident Types GAAPC vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Gateway Analytical, an Aptar Pharma company in 2026.

Incident History - GAAPC (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Gateway Analytical, an Aptar Pharma company Subsidiaries

GAAPC

Pharmaceutical Manufacturing

Website: http://www.gatewayanalytical.com

Company Size: 40

AptarPackaging and Containers Manufacturing

Nanopharm Ltd, an Aptar Pharma CompanyPharmaceutical Manufacturing

FusionPKGPersonal Care Product Manufacturing

Aptar CSP TechnologiesPackaging and Containers Manufacturing

Noble, An Aptar Pharma CompanyPharmaceutical Manufacturing

Next BreathPharmaceutical Manufacturing

Aptar Digital HealthMedical Equipment Manufacturing

InsuliaMedical Device

OleenaHealth and Human Services

Loading…

Gateway Analytical, an Aptar Pharma company Similar Companies

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Loading…

NEWS

Gateway Analytical, an Aptar Pharma company CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 15, 2023 07:00 AM

Testing, Inspection and Certification Market To Power And Cross USD 327.73 Billion By 2032

Testing, Inspection and Certification Market is valued at USD 221.40 Billion and it is expected to Grow around USD 327.73 Billion in.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-81934

SUMMARY

Redis contains a use-after-free vulnerability in the 'tlsProcessPendingData()' function, which handles the TLS pending-data list if Redis is configured with TLS support. A remote, unauthenticated attacker may be able to execute arbitrary commands with the privileges of the Redis server. Fixed in Redis 8.2.9, 8.4.6, 8.6.6, 8.8.2, and 8.10.1.

Published

Date2026-08-27

Updated

Date2026-08-27

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

3.9

REFERENCES

CVE-2026-81931

SUMMARY

Unrestricted Upload of File with Dangerous Type in the product photo upload in Roskus Prospero Flow CRM before 5.16.0 allows an authenticated user holding the create product permission (routine Seller role) to execute arbitrary JavaScript in the application origin. The photo validation rule classifies the file only by its content (magic bytes) and rejects only a fixed list of PHP extensions, while ProductSaveController::save() names the stored file using the client-supplied extension and copies it into the public web root. A file that begins with an image header and carries an HTML extension passes validation, is stored under public/asset/upload/product/, and is served with a text/html content type, turning the upload into first-party stored script execution.

Published

Date2026-08-27

Updated

Date2026-08-27

RISK INFORMATION (Score: )

cvss4

Base Score: 4.8

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-81893

SUMMARY

A flaw was found in gdk-pixbuf. When loading a specially crafted JPEG image containing chunked ICC profile markers, an error during ICC profile parsing can leave stale size metadata after the profile buffer is freed. A subsequent allocation in the same decode can cause an out-of-bounds write, potentially crashing the application. To exploit this flaw, an application using gdk-pixbuf must process the malicious JPEG image. Affected version >= 2.26.4

Published

Date2026-08-27

Updated

Date2026-08-27

RISK INFORMATION (Score: 4.7)

cvss3

Base Score: 4.7

Complexity: HIGH

CVSS:3.1/AV:L/AC:H/PR:N/UI:R/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

REFERENCES

CVE-2026-81838

SUMMARY

A relative path traversal issue in the zip extraction functionality in AWS diagram-as-code (awsdac) in versions 0.10 through 0.23 can allow a third party to write arbitrary files to the local filesystem via crafted zip entry names containing path traversal sequences. This could allow the third party to perform inappropriate actions in the diagram bundle. To remediate this issue, users should upgrade to the version 0.24 or later.

Published

Date2026-08-27

Updated

Date2026-08-27

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:H

cvss4

Base Score: 6.8

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:A/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

1.8

REFERENCES

CVE-2026-81834

SUMMARY

A weakness has been identified in RooCodeInc Roo-Code up to 3.51.1. Affected by this issue is the function ExecaTerminalProcess of the component README File Handler. Executing a manipulation can lead to code injection. The attack can be executed remotely. The exploit has been made available to the public and could be used for attacks. Multiple isses were reported to the vendor beforehand. They explain, that "they all apply to Roo Code, a project we no longer support - the repository was archived a while ago, and we don't encourage anyone to use it." This vulnerability only affects products that are no longer supported by the maintainer.

Published

Date2026-08-27

Updated

Date2026-08-27

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…